Recent developments to share with you

School of Pharmacy, China Pharmaceutical University Holds Plaque Presentation Ceremony with Nanjing Kangchuanji for Graduate Employment Base

2023-04-03


At the beginning of the event, Yin Lifang, General Manager of our company, led the visitors on a “Welcome to Kangchuanji” tour, giving a detailed introduction to the company’s development history, operational scale, talent pool, and main business areas. Subsequently, Zhang Shiying, Secretary of the Party Committee of the School of Pharmacy, introduced the school’s basic situation in terms of its history, number of faculty and students, and research capabilities. Meng Xiangkang, Deputy Secretary of the Party Committee of the School, shared the scale of the 2023 graduating class and the school’s current overall employment situation. Both sides conducted in-depth discussions on industry-university-research collaboration, student internships and apprenticeships, and graduate employment, further clarifying their intentions and exploring ways to cooperate.

On the morning of March 23, a delegation from the School of Pharmacy, China Pharmaceutical University visited our company for an exchange and held the “Graduate Employment Base of the School of Pharmacy, China Pharmaceutical University” plaque presentation ceremony. Attendees included Zhang Shiying (Secretary of the School’s Party Committee), Meng Xiangkang (Deputy Secretary), and graduation class advisors from the school, as well as Yin Lifang (General Manager of our company), Zhu Chunli (Deputy General Manager), Zhao Gang (Deputy General Manager), and Huang Huiwen (Deputy General Manager).

After the exchange, Secretary Zhang Shiying and General Manager Yin Lifang, as representatives of both sides, held the plaque presentation ceremony for the School’s Graduate Employment Base.

Following the ceremony, Deputy General Manager Zhu Chunli led the visitors on a tour of our laboratory, providing a detailed introduction to its scale and equipment.

This event aims to make full use of the universityenterprise cooperation platform. Adhering to the principles of mutual collaboration, mutual benefit, and shared development, both sides will continue to expand their cooperation channels, promote joint growth, provide students with more and better learning, practice, and employment opportunities, and inject new vitality into the company. We look forward to extending our cooperation into broader and deeper areas.

Keywords:

Related information

Good news keeps pouring in: Jiuzhou Pharmaceutical’s Kangchuanji Pharmaceutical has helped its partner obtain marketing approval for Rosuvastatin–Ezetimibe Tablets (I).

Good news keeps pouring in: Jiuzhou Pharmaceutical’s Kangchuanji Pharmaceutical has helped its partner obtain marketing approval for Rosuvastatin–Ezetimibe Tablets (I).

2026-07-03

Good News | Kangchuanji Pharmaceutical’s Sildenafil Citrate Orally Disintegrating Tablets Have Been Approved for Market Launch

According to the drug approval document delivery information released by the NMPA, sildenafil citrate orally disintegrating tablets manufactured by Nanjing Kangchuanji Pharmaceutical Technology Co., Ltd. have been approved for marketing as a Class 4 generic drug under the new chemical drug registration classification, and are deemed to have passed the consistency evaluation.

2026-06-29

A Strong Start to the New Year – Kangchuanji Achieves Multiple Approvals

The new year begins with a wave of good news. Nanjing Kangchuanji Pharmaceutical Technology Co., Ltd. has made an excellent start, backed by professional expertise. According to NMPA drug approval information, the following products have been approved for marketing or have passed consistency evaluation: Famotidine Injection (2ml:20mg), Saxagliptin and Metformin Hydrochloride Extended-Release Tablets (2.5/1000mg and 5/1000mg), Isosorbide Dinitrate Tablets (5mg), Vitamin B6 Injection (100mg/ml), Cefdinir Granules (50mg/0.5g), and Ambroxol and Clenbuterol Oral Solution (1ml: ambroxol hydrochloride 1.5mg and clenbuterol hydrochloride 1μg). Among these, Isosorbide Dinitrate Tablets are the first in China to pass consistency evaluation. As a partner, Kangchuanji provided solid pharmaceutical R&D services, successfully supporting these drugs through the review and approval process.

2026-03-23